Carl DeSantis - 03 Nov 2021 Form 4 Insider Report for INTEGRATED BIOPHARMA INC (INBP)

Role
Director, 10%+ Owner
Signature
/s/ Carl DeSantis
Issuer symbol
INBP
Transactions as of
03 Nov 2021
Net transactions value
$0
Form type
4
Filing time
04 Nov 2021, 12:16:43 UTC
Previous filing
15 Jun 2021
Next filing
02 Dec 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INBP Stock Option (right to buy) Award $0 +50,000 $0.000000 50,000 03 Nov 2021 Common Stock 50,000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Exercise Price of the Stock Option will be 110% of the closing price of the Issuer's Common Stock five trading days after the filing of the Issuer's Quarterly Report on Form 10-Q for the period ended September 30, 2021, with the Securities and Exchange Commission(the "Issue Date").
F2 The option vests and becomes exercisable as follows: 25% (12,500 shares) on the Issue Date, 25% (12,500 shares) on December 31, 2021, 25% (12,500 shares) on March 31, 2022 and 25% (12,500 shares) on June 30, 2022.